SCHEMBL7572881

SCHEMBL7572881

C=CCC1Oc2ccccc2NC1=O

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.53
ALDH1A1 P00352 3/20 0.51
HPGD P15428 1/20 0.51
GAA P10253 1/20 0.49
TSHR P16473 2/20 0.48
USP2 O75604 2/20 0.46
TP53 P04637 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MAPK1 P28482 1/20 0.46
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5670577 0.79 L3MBTL1 (0.58) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL3249363 0.79 PARP1 (0.62) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL3641415 0.78 PARP1 (0.56) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL4821188 0.76 PARP1 (0.58) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL5670687 0.76 ALDH1A1 (0.56) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL5671330 0.76 PARP1 (0.54) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL5670842 0.75 ALDH1A1 (0.65) ALDH1A1HPGDGAATSHRUSP2
SCHEMBL5670690 0.74 PARP1 (0.55) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL22186873 0.74 PARP1 (0.51) PARP1ALDH1A1HPGDGAATSHR
SCHEMBL5671346 0.74 ALDH1A1 (0.54) PARP1ALDH1A1HPGDGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206458-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THE USE THEREOF IN MEDICAMENTS Schering Aktiengesellschaft (DE) 2002-05-22 EP disclosed
WO-2001014347-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THE USE THEREOF IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2001-03-01 WO disclosed